Official AMFI data
Arthkar — Understand Money, Invest Smartly
Computed from real daily NAV — not projections

₹2,000 Monthly SIP in NIPPON INDIA PHARMA FUND for 10 Years

If you had started a ₹2,000/month SIP on 31 Aug 2016 and never stopped — through every crash and rally — here is exactly what happened, using NIPPON INDIA PHARMA FUND's actual NAV for all 121 installments.

You invested

₹2,42,000

121 installments

Value today

₹6,70,510

31 Aug 2026

Absolute gain

+₹4,28,510

+177.1%

XIRR (annualised)

19.2%

money-weighted

The journey, month by month

Portfolio value Amount invested

Worst fall on the way

-19.5%

Deepest drop from peak. This is what you had to sit through.

Corrections survived

4

Falls of 10%+ during the period. Every one recovered.

Same SIP in a fixed deposit

₹3,37,634

Modelled at historical FD rates. The fund beat FD by ₹3,32,876.

Year-by-year progress

YearInvestedValueOverall gain
Year 1 (31 Aug 2017)₹26,000₹23,652-9%
Year 2 (31 Aug 2018)₹50,000₹59,631+19.3%
Year 3 (3 Sept 2019)₹76,000₹76,912+1.2%
Year 4 (31 Aug 2020)₹98,000₹1,46,460+49.4%
Year 5 (31 Aug 2021)₹1,22,000₹2,48,653+103.8%
Year 6 (1 Sept 2022)₹1,48,000₹2,43,968+64.8%
Year 7 (31 Aug 2023)₹1,70,000₹3,36,414+97.9%
Year 8 (2 Sept 2024)₹1,96,000₹5,38,314+174.7%
Year 9 (1 Sept 2025)₹2,20,000₹5,60,897+155%
Year 10 (31 Aug 2026)₹2,42,000₹6,70,510+177.1%

Best year of the journey: Year 8 (+48.5% market move) · Toughest year: Year 6 (-11.2%)

Wealth Time Machine

Watch this exact journey as a 60-second cinematic replay

Every crash headline, every recovery — with your money in it.

Try a different amount

Try a different duration

Same SIP in other Sectoral / Thematic funds

Past performance does not guarantee future returns. This page shows the historical result of the stated SIP using NIPPON INDIA PHARMA FUND's published NAV (source: AMFI) between 31 Aug 2016 and 31 Aug 2026; it is educational research, not investment advice. FD comparison is modelled at historical average FD rates. Mutual fund investments are subject to market risks.